Literature DB >> 8572209

Fourth ventricle injection of corticotropin-releasing factor and gastric emptying of glucose during gastric fill.

U Smedh1, K Uvnäs-Moberg, H J Grill, J M Kaplan.   

Abstract

The effect of corticotropin-releasing factor (CRF) administered into the fourth ventricle on the gastric emptying of a 12-ml intragastric infusion of 12.5% D-glucose was examined in nondeprived male rats. All three CRF doses tested (10, 100, and 1,000 pmol) significantly reduced (by 28, 29, and 44%, respectively) the amount of glucose emptied from the stomach at the end of the 12-min (1.0 ml/min) gastric infusion interval. The 10 pmol effective dose is the lowest yet reported to influence gastric emptying. The receptor specificity of the exogenous CRF (1,000 pmol) effect was demonstrated by its complete blockade by preinjection of alpha-helical CRF-9-41 (10 nmol) into the fourth ventricle. Injection of the antagonist alone, however, did not affect glucose emptying, indicating little activation of the targeted receptors under the present nonstressful, baseline conditions. Our results suggest that of the central CRF receptor systems that influence gastric emptying, those in the caudal brain stem, targeted by fourth ventricular injection, may be of particular importance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8572209     DOI: 10.1152/ajpgi.1995.269.6.G1000

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Fourth ventricular thyrotropin induces satiety and increases body temperature in rats.

Authors:  Ulrika Smedh; Karen A Scott; Timothy H Moran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-01-03       Impact factor: 3.619

Review 2.  Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract.

Authors:  Yvette Tache; Muriel Larauche; Pu-Qing Yuan; Mulugeta Million
Journal:  Curr Mol Pharmacol       Date:  2018       Impact factor: 3.339

3.  Intracisternal urocortin inhibits vagally stimulated gastric motility in rats: role of CRF(2).

Authors:  C-Y Chen; M Million; D W Adelson; V Martínez; J Rivier; Y Taché
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

Review 4.  Neuroendocrine control of the gut during stress: corticotropin-releasing factor signaling pathways in the spotlight.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Annu Rev Physiol       Date:  2009       Impact factor: 19.318

5.  In vitro and in vivo analysis of the effects of corticotropin releasing factor on rat dorsal vagal complex.

Authors:  Mark W Lewis; Gerlinda E Hermann; Richard C Rogers; R Alberto Travagli
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

6.  Antagonism of corticotrophin-releasing factor receptors in the fourth ventricle modifies responses to mild but not restraint stress.

Authors:  Joanna R Miragaya; Ruth B S Harris
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-06-11       Impact factor: 3.619

7.  Pretreatment with a CRF antagonist amplifies feeding inhibition induced by fourth ventricular cocaine- and amphetamine-regulated transcript peptide.

Authors:  Ulrika Smedh; Karen A Scott; Timothy H Moran
Journal:  BMC Neurosci       Date:  2019-03-18       Impact factor: 3.288

8.  Pituitary adenylate cyclase-activating polypeptide 6-38 blocks cocaine- and amphetamine-regulated transcript Peptide-induced hypophagia in rats.

Authors:  Jonathan R Burgos; Britt-Marie Iresjö; Ulrika Smedh
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.